Ubrolexin Boehringer Ingelheim
Ubrolexin Boehringer Ingelheim – product information
Each tube contains:
Cefalexin (as monohydrate): 200 mg
Kanamycin (as monosulphate): 100,000 I.U.
Treatment of clinical mastitis in lactating dairy cows for bacteria susceptible to the combination of cefalexin and kanamycin such as Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.
Dosage & Administration
Treat the infected quarter(s) twice, leaving an interval of 24 hours between treatments.